Deferasirox/deferiprone/deferoxamineMaculopapular eruption, skin eruption and agranulocytosis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1858卷 / 1期

关键词：

D O I：

10.1007/s40278-021-96850-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：132 / 132

相关论文

共 50 条

[41] Sodium picosulfateBullous skin eruption: case report
Reactions Weekly, 2012, 1418 (1) : 41 - 41
[42] TrimebutinePruritic morbilliform skin eruption: case report
Reactions Weekly, 2019, 1773 (1) : 311 - 311
[43] AntineoplasticsHaematological toxicity and skin eruption: case report
Reactions Weekly, 2022, 1931 (1) : 66 - 66
[44] LenalidomideParonychia (first report) and skin eruption: case report
Reactions Weekly, 2013, 1456 (1) : 21 - 21
[45] VaccinesBullous skin eruption and fever: case report
Reactions Weekly, 2021, 1870 (1) : 307 - 307
[46] Ipilimumab/nivolumabLichenoid skin eruption : case report
Reactions Weekly, 2023, 1963 (1) : 301 - 301
[47] Strontium ranelateGeneralised skin eruption: case report
Reactions Weekly, 2009, 1249 (1) : 41 - 41
[48] Deferasirox/deferiprone/deferoxamineLack of efficacy: case report
Reactions Weekly, 2021, 1886 (1) : 158 - 158
[49] Deferasirox/deferiprone/deferoxamineRetinal dystrophy: case report
Reactions Weekly, 2022, 1924 (1) : 180 - 180
[50] Erlotinib/minocyclinePapulopustular skin eruption and skin hyperpigmentation: case report
Reactions Weekly, 2017, 1656 (1) : 210 - 210

← 1 2 3 4 5 →